Test-retest reliability of quantitative MRI parameters in a prospective single-center neurooncological imaging study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00011651

Enrollment

Registered

2017-01-27

Start date

2017-01-16

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intra-session test-retest reliability of quantitative MRI parameters in neurooncological MRI imaging of the brain C71

Interventions

Group 1: We aim to investigate the test-retest reliability of quantitative MRI parameters in a prospective single-center group of patients with neurooncological diagnosis and routine follow-up head MR

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -age > 18 -capacity to consent to treatment as defined under German law -supratentorial intraaxial or mainly supratentorial intraaxial tumor that has been histologically proven -supratentorial contrast enhancement = 3 x 3 x 3 mm -appointment for routine follow-up MRI of the brain -isovolumetric contrast-enhanced and isovolumetirc T1w volume in routine follow-up MRI imaging

Exclusion criteria

Exclusion criteria: - pregnancy - inflammatory CNS disease - pronounced motion artefacts - adipositas per magna

Design outcomes

Primary

Measure	Time frame
intraclass correlation coefficient of quantitative MRI parameters	—

Countries

Germany

Contacts

Public ContactPhilipp Kickingereder

Abt. Neuroradiologie - Universitätsklinikum Heidelberg

philipp.kickingereder@med.uni-heidelberg.de06221 56-7566

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026